News
YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill. The initial preclinical studies, funded in part by the…
Dr. Gunda Georg was awarded the 2023 Carl Mannich Medal by the Deutsche Pharmazeutische Gesellschaft e.V. (DPhG) (…
The laboratories of Dr. Gunda Georg and Dr. Daniel Harki collaborated on a recent publication in Nature Communications regarding the discovery of a new allosteric inhibitors that bind to CDK2.
Cyclin-dependent kinase 2 (CDK2), part of the enzyme family responsible for controlling…